Skip to content

ADAR1 Capital Management, LLC

Follow

13F filer, CIK 1940272, AUSTIN, TX

ADAR1 Capital Management, LLC reported $1,361,602,179 across 270 holdings for the quarter ended 2025-12-31, in a 13F-HR/A filed 2026-02-18. Its ten largest share positions make up 45.99% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR/A 0001940272-26-000003

Period
2025-12-31
Reported value
$1.36B
Holdings
270
Top 10 weight
45.99%
New
90
Sold out
37

Stakes and trades reported after 2025-12-31

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

Largest buys vs the previous quarter

SecurityShares changeApprox. value
RNAMadded+492,878$35.6M
TERNadded+531,615$21.5M
CLDXadded+537,325$14.6M
IVAnew+2,709,846$12.6M
ABUSadded+2,511,883$12.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
KROSreduced-5,370,413-$109M
89BIO INCexited-2,113,153-$31.1M
BIOAreduced-1,744,513-$23.1M
IVVDreduced-3,471,590-$8.57M
MTSRexited-152,521-$7.98M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR/A 0001940272-26-000003, largest first. % of portfolio is the value over $1,336,950,710, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 521,612 shares; 2024Q4: 1,513,393 shares; 2025Q1: 2,210,019 shares; 2025Q2: 3,071,340 shares; 2025Q3: 1,350,826 shares; 2025Q4: 1,317,329 shares 1,317,329$178M13.29%-33,497Timeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 981,295 shares; 2024Q4: 1,020,333 shares; 2025Q1: 939,669 shares; 2025Q2: 948,069 shares; 2025Q3: 989,182 shares; 2025Q4: 1,049,168 shares 1,049,168$91.6M6.85%+59,986Timeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,025,450 shares; 2024Q4: 3,508,694 shares; 2025Q1: 3,483,404 shares; 2025Q2: 1,940,797 shares; 2025Q3: 3,347,501 shares; 2025Q4: 3,428,962 shares 3,428,962$74.4M5.57%+81,461Timeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,131,707 shares; 2024Q4: 787,478 shares; 2025Q1: 968,866 shares; 2025Q2: 535,066 shares; 2025Q3: 2,241,753 shares; 2025Q4: 2,480,968 shares 2,480,968$63.1M4.72%+239,215Timeline
RNAMAVIDITY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 600 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 53,656 shares; 2025Q4: 546,534 shares 546,534$39.4M2.95%+492,878Timeline
BOXXEA SERIES TRUSTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 323,382 shares; 2024Q4: 325,450 shares; 2025Q1: 337,125 shares; 2025Q2: 337,125 shares; 2025Q3: 337,125 shares; 2025Q4: 337,125 shares 337,125$38.8M2.9%0Timeline
SPYSTATE STR SPDR S&P 500 ETF TQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 22,684 shares; 2025Q3: 54,684 shares; 2025Q4: 54,684 shares 54,684$37.3M2.79%0Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 911,182 shares; 2024Q4: 414,209 shares; 2025Q1: 390,729 shares; 2025Q2: 582,147 shares; 2025Q3: 518,921 shares; 2025Q4: 540,166 shares 540,166$34.3M2.57%+21,245Timeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 720,848 shares; 2025Q2: 847,227 shares; 2025Q3: 1,176,491 shares; 2025Q4: 1,157,611 shares 1,157,611$32.3M2.41%-18,880Timeline
ABUSARBUTUS BIOPHARMA CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,089,321 shares; 2024Q4: 1,554,802 shares; 2025Q1: 1,879,114 shares; 2025Q2: 2,825,773 shares; 2025Q3: 2,903,226 shares; 2025Q4: 5,415,109 shares 5,415,109$26M1.95%+2,511,883Timeline
ZLABZAI LAB LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 532,454 shares; 2024Q4: 1,045,837 shares; 2025Q1: 940,858 shares; 2025Q2: 850,437 shares; 2025Q3: 868,780 shares; 2025Q4: 1,246,520 shares 1,246,520$22M1.64%+377,740Timeline
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 24,702 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 28,415 shares; 2025Q3: 10,000 shares; 2025Q4: 541,615 shares 541,615$21.9M1.64%+531,615Timeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 903,959 shares; 2024Q4: 145,036 shares; 2025Q1: 47,036 shares; 2025Q2: 3,081,414 shares; 2025Q3: 4,045,414 shares; 2025Q4: 4,182,769 shares 4,182,769$17.8M1.33%+137,355Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,000 shares; 2024Q4: not reported; 2025Q1: 14,600 shares; 2025Q2: 57,466 shares; 2025Q3: 109,442 shares; 2025Q4: 646,767 shares 646,767$17.6M1.31%+537,325Timeline
RAPTRAPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 783,217 shares; 2025Q3: 507,771 shares; 2025Q4: 509,679 shares 509,679$17.3M1.29%+1,908Timeline
IKTINHIBIKASE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 5,103,005 shares; 2025Q1: 5,122,105 shares; 2025Q2: 5,122,105 shares; 2025Q3: 5,247,603 shares; 2025Q4: 8,063,949 shares 8,063,949$16.5M1.24%+2,816,346Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,448,470 shares; 2024Q4: 678,857 shares; 2025Q1: 339,635 shares; 2025Q2: 259,659 shares; 2025Q3: 273,414 shares; 2025Q4: 213,414 shares 213,414$16.3M1.22%-60,000Timeline
MNPRMONOPAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 130,037 shares; 2025Q1: 100,774 shares; 2025Q2: 100,974 shares; 2025Q3: 129,999 shares; 2025Q4: 233,908 shares 233,908$15.3M1.14%+103,909Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,097 shares; 2024Q4: not reported; 2025Q1: 12,800 shares; 2025Q2: 98,032 shares; 2025Q3: 213,064 shares; 2025Q4: 315,642 shares 315,642$14.6M1.09%+102,578Timeline
CRNXCRINETICS PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 88,425 shares; 2024Q4: 53,125 shares; 2025Q1: 53,125 shares; 2025Q2: 53,125 shares; 2025Q3: 248,368 shares; 2025Q4: 309,368 shares 309,368$14.4M1.08%+61,000Timeline
FULCFULCRUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 55,802 shares; 2024Q4: 196,248 shares; 2025Q1: 490,532 shares; 2025Q2: 53,349 shares; 2025Q3: 341,612 shares; 2025Q4: 1,253,749 shares 1,253,749$14.2M1.06%+912,137Timeline
PRTAPROTHENA CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 3,375,009 shares; 2025Q3: 1,469,098 shares; 2025Q4: 1,457,764 shares 1,457,764$13.9M1.04%-11,334Timeline
LXEOLEXEO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 57,166 shares; 2024Q4: 169,505 shares; 2025Q1: 170,448 shares; 2025Q2: 145,109 shares; 2025Q3: 1,531,953 shares; 2025Q4: 1,393,161 shares 1,393,161$13.8M1.03%-138,792Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 251,400 shares; 2024Q4: 177,707 shares; 2025Q1: 1,066,309 shares; 2025Q2: 3,009,870 shares; 2025Q3: 2,835,680 shares; 2025Q4: 2,495,809 shares 2,495,809$13.7M1.03%-339,871Timeline
CDTXCIDARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 24,938 shares; 2025Q1: 20,938 shares; 2025Q2: 21,522 shares; 2025Q3: 21,522 shares; 2025Q4: 59,677 shares 59,677$13.2M0.99%+38,155Timeline
IVAINVENTIVA SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,709,846 shares 2,709,846$12.6M0.94%newTimeline
ESTAESTABLISHMENT LABS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,000 shares; 2024Q4: not reported; 2025Q1: 8,000 shares; 2025Q2: 25,000 shares; 2025Q3: 90,688 shares; 2025Q4: 171,422 shares 171,422$12.5M0.93%+80,734Timeline
BILSPDR SERIES TRUSTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 21,786 shares; 2024Q4: 131,786 shares; 2025Q1: 135,585 shares; 2025Q2: 135,585 shares; 2025Q3: 135,585 shares; 2025Q4: 135,585 shares 135,585$12.4M0.93%0Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,400 shares; 2025Q3: 978,894 shares; 2025Q4: 1,241,322 shares 1,241,322$12.1M0.9%+262,428Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 700 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 148,461 shares; 2025Q3: 133,818 shares; 2025Q4: 147,130 shares 147,130$11.6M0.87%+13,312Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 44,351 shares; 2024Q4: 170,000 shares; 2025Q1: 177,136 shares; 2025Q2: 134,136 shares; 2025Q3: 139,136 shares; 2025Q4: 145,079 shares 145,079$11.6M0.86%+5,943Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 220,906 shares; 2024Q4: not reported; 2025Q1: 1,471,587 shares; 2025Q2: 1,205,101 shares; 2025Q3: 866,202 shares; 2025Q4: 890,356 shares 890,356$10.8M0.8%+24,154Timeline
CGONCG ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 143,104 shares; 2024Q4: 215,750 shares; 2025Q1: 301,134 shares; 2025Q2: 523,216 shares; 2025Q3: 248,917 shares; 2025Q4: 258,139 shares 258,139$10.7M0.8%+9,222Timeline
TFXTELEFLEX INCORPORATEDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 80,627 shares 80,627$9.84M0.74%newTimeline
IVVDINVIVYD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 7,370,987 shares; 2025Q4: 3,899,397 shares 3,899,397$9.63M0.72%-3,471,590Timeline
REGNREGENERON PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 871 shares; 2024Q4: 1,361 shares; 2025Q1: 1,361 shares; 2025Q2: 3,361 shares; 2025Q3: 15,700 shares; 2025Q4: 12,051 shares 12,051$9.3M0.7%-3,649Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 27,903 shares; 2024Q4: 50,547 shares; 2025Q1: 127,548 shares; 2025Q2: 259,503 shares; 2025Q3: 189,098 shares; 2025Q4: 203,969 shares 203,969$9.14M0.68%+14,871Timeline
EQEQUILLIUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,318 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 5,559,988 shares; 2025Q4: 5,608,078 shares 5,608,078$8.69M0.65%+48,090Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 742,634 shares; 2024Q4: 988,468 shares; 2025Q1: 1,360,291 shares; 2025Q2: 3,600,670 shares; 2025Q3: 1,988,288 shares; 2025Q4: 1,405,452 shares 1,405,452$8.47M0.63%-582,836Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 26,045 shares; 2025Q4: 179,532 shares 179,532$7.44M0.56%+153,487Timeline
TEVATEVA PHARMACEUTICAL INDS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 108,171 shares; 2024Q4: 146,671 shares; 2025Q1: 523,767 shares; 2025Q2: 345,878 shares; 2025Q3: 267,816 shares; 2025Q4: 235,971 shares 235,971$7.36M0.55%-31,845Timeline
CBIOCRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 606,000 shares 606,000$7.19M0.54%newTimeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 37,743 shares; 2024Q4: 130,532 shares; 2025Q1: 115,867 shares; 2025Q2: 115,867 shares; 2025Q3: 12,846 shares; 2025Q4: 4,285,000 shares 4,285,000$6.98M0.52%+4,272,154Timeline
BLTEBELITE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 39,839 shares 39,839$6.37M0.48%newTimeline
VRTXVERTEX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 7,000 shares; 2025Q4: 13,716 shares 13,716$6.22M0.47%+6,716Timeline
BHFBRIGHTHOUSE FINL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 10,000 shares; 2025Q4: 95,523 shares 95,523$6.19M0.46%+85,523Timeline
AVRANTERIS TECHNOLOGIES GLOBALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,052,968 shares; 2025Q1: 1,678,063 shares; 2025Q2: 531,515 shares; 2025Q3: 197,615 shares; 2025Q4: 1,238,777 shares 1,238,777$6.18M0.46%+1,041,162Timeline
AAMAA MISSION ACQUISITION COR-AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,010,199 shares; 2024Q4: 560,199 shares; 2025Q1: 578,359 shares; 2025Q2: 578,359 shares; 2025Q3: 578,359 shares; 2025Q4: 578,359 shares 578,359$6.17M0.46%0Timeline
TARAPROTARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 122,690 shares; 2025Q1: 122,690 shares; 2025Q2: 122,690 shares; 2025Q3: 35,223 shares; 2025Q4: 1,136,799 shares 1,136,799$6.06M0.45%+1,101,576Timeline
FRNMPERCEPTIVE CAP SOLUTIONS CORQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 750,000 shares; 2024Q4: 750,000 shares; 2025Q1: 750,000 shares; 2025Q2: 750,000 shares; 2025Q3: 750,000 shares; 2025Q4: 456,720 shares 456,720$5.95M0.45%-293,280Timeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 4,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 25,600 shares 25,600$5.86M0.44%newTimeline
CLYMCLIMB BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 163,443 shares; 2024Q4: 48,125 shares; 2025Q1: 119,320 shares; 2025Q2: 119,320 shares; 2025Q3: 133,530 shares; 2025Q4: 1,432,475 shares 1,432,475$5.73M0.43%+1,298,945Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 10,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 133,316 shares; 2025Q4: 235,155 shares 235,155$5.63M0.42%+101,839Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 30,941 shares; 2025Q1: 36,890 shares; 2025Q2: 45,390 shares; 2025Q3: 49,571 shares; 2025Q4: 51,349 shares 51,349$5.5M0.41%+1,778Timeline
OACCUOAKTREE ACQUISITION CORP IIIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 500,000 shares; 2025Q1: 516,482 shares; 2025Q2: 516,482 shares; 2025Q3: 516,482 shares; 2025Q4: 516,482 shares 516,482$5.49M0.41%0Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 161,402 shares; 2024Q4: 71,402 shares; 2025Q1: 1,402 shares; 2025Q2: 1,402 shares; 2025Q3: 36,345 shares; 2025Q4: 25,314 shares 25,314$5.4M0.4%-11,031Timeline
AGIOAGIOS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 21,300 shares; 2024Q4: not reported; 2025Q1: 27,900 shares; 2025Q2: 35,900 shares; 2025Q3: 37,000 shares; 2025Q4: 188,000 shares 188,000$5.12M0.38%+151,000Timeline
SPRBSPRUCE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 58,000 shares 58,000$5.05M0.38%newTimeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 729,401 shares; 2024Q4: 841,541 shares; 2025Q1: 263,425 shares; 2025Q2: 302,125 shares; 2025Q3: 78,238 shares; 2025Q4: 136,231 shares 136,231$4.94M0.37%+57,993Timeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 100 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 18,523 shares; 2025Q4: 20,014 shares 20,014$4.93M0.37%+1,491Timeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,004,845 shares 2,004,845$4.71M0.35%newTimeline
SPRYARS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 59,230 shares; 2025Q4: 369,569 shares 369,569$4.31M0.32%+310,339Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 29,625 shares; 2024Q4: 3,045 shares; 2025Q1: 4,500 shares; 2025Q2: 5,100 shares; 2025Q3: 18,000 shares; 2025Q4: 24,300 shares 24,300$4.28M0.32%+6,300Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 112,359 shares; 2025Q3: 114,359 shares; 2025Q4: 118,623 shares 118,623$4.16M0.31%+4,264Timeline
AEXAAMERICAN EXCEPTIONALISM ACQUQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares; 2025Q4: 357,539 shares 357,539$4.07M0.3%+307,539Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 11,705 shares; 2024Q4: 12,900 shares; 2025Q1: 56,300 shares; 2025Q2: 55,200 shares; 2025Q3: 49,800 shares; 2025Q4: 58,200 shares 58,200$3.86M0.29%+8,400Timeline
ATAIBECKLEY INCATAIBECKLEY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 100,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 913,242 shares; 2025Q4: 913,242 shares 913,242$3.74M0.28%0
CRVSCORVUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 465,875 shares 465,875$3.59M0.27%newTimeline
JANXJANUX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 13,000 shares; 2024Q4: 31,509 shares; 2025Q1: 153,767 shares; 2025Q2: 62,088 shares; 2025Q3: 351,032 shares; 2025Q4: 245,452 shares 245,452$3.39M0.25%-105,580Timeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 215,752 shares; 2025Q4: 215,752 shares 215,752$3.38M0.25%0Timeline
AVADEL PHARMACEUTICALSAVADEL PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 80,900 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 150,532 shares 150,532$3.24M0.24%new
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 8,967 shares; 2024Q4: 82,234 shares; 2025Q1: 168,765 shares; 2025Q2: 166,799 shares; 2025Q3: 77,961 shares; 2025Q4: 278,961 shares 278,961$3.19M0.24%+201,000Timeline
EVMNEVOMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 184,062 shares 184,062$3.15M0.24%newTimeline
SNYSANOFI SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 99,600 shares; 2025Q1: not reported; 2025Q2: 10,000 shares; 2025Q3: 74,212 shares; 2025Q4: 63,474 shares 63,474$3.08M0.23%-10,738Timeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 12,000 shares; 2024Q4: 19,505 shares; 2025Q1: 157,079 shares; 2025Q2: 39,677 shares; 2025Q3: 20,087 shares; 2025Q4: 69,589 shares 69,589$3.07M0.23%+49,502Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 15,796 shares; 2025Q3: 72,007 shares; 2025Q4: 72,031 shares 72,031$3.05M0.23%+24Timeline
IWMISHARES TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 12,070 shares 12,070$2.97M0.22%newTimeline
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,770,649 shares; 2024Q4: 2,077,251 shares; 2025Q1: 2,801,184 shares; 2025Q2: 997,547 shares; 2025Q3: 652,154 shares; 2025Q4: 562,065 shares 562,065$2.95M0.22%-90,089Timeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares; 2025Q3: not reported; 2025Q4: 1,014,158 shares 1,014,158$2.94M0.22%newTimeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares; 2025Q3: 35,000 shares; 2025Q4: 125,375 shares 125,375$2.94M0.22%+90,375Timeline
LONALEONABIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 393,701 shares 393,701$2.89M0.22%newTimeline
BBOTBRIDGEBIO ONCOLOGY THERAPEUTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 501,228 shares; 2025Q4: 226,248 shares 226,248$2.83M0.21%-274,980Timeline
ELDNELEDON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 16,000 shares; 2025Q1: 16,600 shares; 2025Q2: 16,900 shares; 2025Q3: not reported; 2025Q4: 1,821,812 shares 1,821,812$2.75M0.21%newTimeline
ENGNENGENE HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,970 shares; 2024Q4: not reported; 2025Q1: 23,799 shares; 2025Q2: 27,787 shares; 2025Q3: not reported; 2025Q4: 303,686 shares 303,686$2.74M0.21%newTimeline
DVAXDYNAVAX TECHNOLOGIES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 170,000 shares; 2025Q2: 170,000 shares; 2025Q3: 170,000 shares; 2025Q4: 170,000 shares 170,000$2.61M0.2%0Timeline
INOINOVIO PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,485,008 shares 1,485,008$2.58M0.19%newTimeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 9,206 shares; 2024Q4: 26,000 shares; 2025Q1: 79,000 shares; 2025Q2: 170,598 shares; 2025Q3: 101,704 shares; 2025Q4: 77,198 shares 77,198$2.4M0.18%-24,506Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 34,124 shares; 2025Q3: 34,124 shares; 2025Q4: 85,528 shares 85,528$2.37M0.18%+51,404Timeline
CRBPCORBUS PHARMACEUTICALS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 10,200 shares; 2025Q4: 286,781 shares 286,781$2.33M0.17%+276,581Timeline
ASTRIA THERAPEUTICS INCASTRIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 93,284 shares; 2024Q4: 90,984 shares; 2025Q1: 641,690 shares; 2025Q2: 249,646 shares; 2025Q3: 193,934 shares; 2025Q4: 173,557 shares 173,557$2.27M0.17%-20,377
DCTHDELCATH SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 31,052 shares; 2024Q4: 149,385 shares; 2025Q1: 149,385 shares; 2025Q2: 149,385 shares; 2025Q3: 224,385 shares; 2025Q4: 224,385 shares 224,385$2.27M0.17%0Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 18,178 shares; 2024Q4: not reported; 2025Q1: 20,000 shares; 2025Q2: 40,000 shares; 2025Q3: 40,000 shares; 2025Q4: 90,999 shares 90,999$2.26M0.17%+50,999Timeline
GRCEGRACE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 959,571 shares; 2024Q4: 773,635 shares; 2025Q1: 343,512 shares; 2025Q2: 176,627 shares; 2025Q3: 350,450 shares; 2025Q4: 641,988 shares 641,988$2.22M0.17%+291,538Timeline
RGNXREGENXBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 569,008 shares; 2024Q4: 170,129 shares; 2025Q1: 350,352 shares; 2025Q2: 207,818 shares; 2025Q3: 205,409 shares; 2025Q4: 144,848 shares 144,848$2.09M0.16%-60,561Timeline
ACLXARCELLX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,962 shares; 2024Q4: 3,962 shares; 2025Q1: 13,962 shares; 2025Q2: 13,962 shares; 2025Q3: 31,484 shares; 2025Q4: 31,484 shares 31,484$2.05M0.15%0Timeline
OLMAOLEMA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 36,200 shares; 2025Q4: 81,399 shares 81,399$2.03M0.15%+45,199Timeline
MASIMASIMO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,894 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 15,000 shares; 2025Q4: 15,000 shares 15,000$1.95M0.15%0Timeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 33,278 shares; 2025Q4: 238,390 shares 238,390$1.95M0.15%+205,112Timeline
SLNOSOLENO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,000 shares; 2024Q4: 36,830 shares; 2025Q1: 18,830 shares; 2025Q2: 17,330 shares; 2025Q3: 25,230 shares; 2025Q4: 41,830 shares 41,830$1.94M0.14%+16,600Timeline
ABOSACUMEN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 94,294 shares; 2025Q1: 146,183 shares; 2025Q2: 916,183 shares; 2025Q3: 891,183 shares; 2025Q4: 891,183 shares 891,183$1.88M0.14%0Timeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 90,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 373,682 shares; 2025Q4: 613,986 shares 613,986$1.85M0.14%+240,304Timeline
PFEPFIZER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 35,950 shares; 2024Q4: 35,050 shares; 2025Q1: 41,050 shares; 2025Q2: 39,400 shares; 2025Q3: 44,400 shares; 2025Q4: 72,400 shares 72,400$1.8M0.13%+28,000Timeline
BIOABIOAGE LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 123,037 shares; 2025Q1: 971,100 shares; 2025Q2: 1,937,123 shares; 2025Q3: 1,880,073 shares; 2025Q4: 135,560 shares 135,560$1.79M0.13%-1,744,513Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 74,431 shares; 2024Q4: 10,188 shares; 2025Q1: not reported; 2025Q2: 45,000 shares; 2025Q3: 56,200 shares; 2025Q4: 63,700 shares 63,700$1.78M0.13%+7,500Timeline
GMEDGLOBUS MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,100 shares 20,100$1.75M0.13%newTimeline
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 428,802 shares; 2024Q4: 368,330 shares; 2025Q1: 380,330 shares; 2025Q2: 1,723,526 shares; 2025Q3: not reported; 2025Q4: 1,108,000 shares 1,108,000$1.73M0.13%newTimeline
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,300 shares; 2024Q4: 211,400 shares; 2025Q1: 241,800 shares; 2025Q2: 275,800 shares; 2025Q3: 575,800 shares; 2025Q4: 475,800 shares 475,800$1.67M0.12%-100,000Timeline
WWWW INTL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 52,450 shares; 2025Q4: 57,100 shares 57,100$1.67M0.12%+4,650Timeline
SMMTSUMMIT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 12,000 shares; 2025Q3: 102,969 shares; 2025Q4: 91,869 shares 91,869$1.61M0.12%-11,100Timeline
CCIIUCOHEN CIRCLE ACQUISIT CORP IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 150,000 shares; 2025Q4: 150,000 shares 150,000$1.56M0.12%0Timeline
SUPNSUPERNUS PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 14,418 shares; 2025Q4: 29,742 shares 29,742$1.48M0.11%+15,324Timeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 6,000 shares; 2025Q4: 15,000 shares 15,000$1.38M0.1%+9,000Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 11,000 shares; 2025Q1: 21,200 shares; 2025Q2: 31,200 shares; 2025Q3: 31,200 shares; 2025Q4: 72,070 shares 72,070$1.37M0.1%+40,870Timeline
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 2,750 shares; 2025Q3: 2,500 shares; 2025Q4: 8,000 shares 8,000$1.36M0.1%+5,500Timeline
OABIOMNIAB INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,337,302 shares; 2024Q4: 278,108 shares; 2025Q1: 126,108 shares; 2025Q2: 326,108 shares; 2025Q3: 1,090,628 shares; 2025Q4: 702,190 shares 702,190$1.3M0.1%-388,438Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 41,346 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 140,021 shares 140,021$1.24M0.09%newTimeline
ADGMADAGIO MED HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 148,861 shares; 2024Q4: 76,757 shares; 2025Q1: 76,757 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,159,614 shares 1,159,614$1.21M0.09%newTimeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 436,668 shares; 2024Q4: 166,406 shares; 2025Q1: 41,412 shares; 2025Q2: 56,540 shares; 2025Q3: 75,187 shares; 2025Q4: 28,728 shares 28,728$1.19M0.09%-46,459Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 12,560 shares; 2024Q4: not reported; 2025Q1: 15,033 shares; 2025Q2: 34,051 shares; 2025Q3: 34,051 shares; 2025Q4: 34,051 shares 34,051$1.12M0.08%0Timeline
ACETADICET BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 128,646 shares 128,646$1.08M0.08%newTimeline
BMYBRISTOL-MYERS SQUIBB COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,000 shares 20,000$1.08M0.08%newTimeline
TNYATENAYA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,505,300 shares 1,505,300$1.07M0.08%newTimeline
BSAAUBEST SPAC I ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 100,000 shares; 2025Q3: 100,000 shares; 2025Q4: 100,000 shares 100,000$1.02M0.08%0Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,140 shares; 2024Q4: 2,440 shares; 2025Q1: not reported; 2025Q2: 7,040 shares; 2025Q3: 18,540 shares; 2025Q4: 9,640 shares 9,640$1.01M0.08%-8,900Timeline
INFQINFLEQTION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 64,887 shares 64,887$1.01M0.08%newTimeline
EAELECTRONIC ARTS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,936 shares; 2025Q4: 4,936 shares 4,936$1.01M0.08%0Timeline
MCKMCKESSON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,850 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,200 shares 1,200$984K0.07%newTimeline
CNTACENTESSA PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 23,302 shares; 2024Q4: 154,027 shares; 2025Q1: 216,166 shares; 2025Q2: 296,766 shares; 2025Q3: 53,666 shares; 2025Q4: 38,566 shares 38,566$965K0.07%-15,100Timeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,000 shares; 2024Q4: not reported; 2025Q1: 5,000 shares; 2025Q2: not reported; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares 10,000$952K0.07%0Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,100 shares; 2024Q4: 9,300 shares; 2025Q1: 59,413 shares; 2025Q2: 67,813 shares; 2025Q3: 175,919 shares; 2025Q4: 26,494 shares 26,494$932K0.07%-149,425Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 11,200 shares; 2025Q4: 1,900 shares 1,900$926K0.07%-9,300Timeline
PLYMPLYMOUTH INDUSTRIAL REIT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 41,065 shares 41,065$899K0.07%newTimeline
FDMT4D MOLECULAR THERAPEUTICS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 6,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 16,712 shares; 2025Q4: 116,712 shares 116,712$875K0.07%+100,000Timeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 101,826 shares; 2024Q4: 44,826 shares; 2025Q1: 13,873 shares; 2025Q2: 35,716 shares; 2025Q3: 51,516 shares; 2025Q4: 52,116 shares 52,116$860K0.06%+600Timeline
XNCRXENCOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 342,262 shares; 2024Q4: 234,607 shares; 2025Q1: 398,152 shares; 2025Q2: 85,826 shares; 2025Q3: 128,865 shares; 2025Q4: 56,165 shares 56,165$860K0.06%-72,700Timeline
KLRSKALARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 100,000 shares 100,000$844K0.06%newTimeline
QNRXQUOIN PHARMACEUTICALS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 58,230 shares 58,230$840K0.06%newTimeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 400 shares; 2024Q4: not reported; 2025Q1: 30,099 shares; 2025Q2: 23,063 shares; 2025Q3: 37,663 shares; 2025Q4: 42,674 shares 42,674$835K0.06%+5,011Timeline
AZNASTRAZENECA PLC-SPONS ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 700 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 9,000 shares 9,000$827K0.06%newTimeline
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 6,666 shares 6,666$818K0.06%newTimeline
AVTRAVANTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares; 2025Q3: 25,000 shares; 2025Q4: 70,000 shares 70,000$802K0.06%+45,000Timeline
AREALEXANDRIA REAL ESTATE EQ INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 16,300 shares 16,300$798K0.06%newTimeline
LUNGPULMONX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 28,221 shares; 2025Q1: not reported; 2025Q2: 204,497 shares; 2025Q3: 214,497 shares; 2025Q4: 355,410 shares 355,410$785K0.06%+140,913Timeline
IBIOIBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 476,212 shares; 2024Q4: 415,606 shares; 2025Q1: not reported; 2025Q2: 54,819 shares; 2025Q3: 27,000 shares; 2025Q4: 405,531 shares 405,531$783K0.06%+378,531Timeline
TENXTENAX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 62,423 shares; 2024Q4: 34,693 shares; 2025Q1: 68,741 shares; 2025Q2: 155,557 shares; 2025Q3: 53,428 shares; 2025Q4: 63,673 shares 63,673$776K0.06%+10,245Timeline
STROSUTRO BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 67,077 shares 67,077$776K0.06%newTimeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,200 shares; 2024Q4: not reported; 2025Q1: 4,900 shares; 2025Q2: 4,900 shares; 2025Q3: 4,900 shares; 2025Q4: 12,900 shares 12,900$767K0.06%+8,000Timeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 25,000 shares; 2025Q3: 50,000 shares; 2025Q4: 139,000 shares 139,000$746K0.06%+89,000Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 14,733 shares 14,733$746K0.06%newTimeline
KZRKEZAR LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,338,273 shares; 2024Q4: 147,404 shares; 2025Q1: 147,404 shares; 2025Q2: 147,404 shares; 2025Q3: 124,967 shares; 2025Q4: 117,440 shares 117,440$739K0.06%-7,527Timeline
VTYXVENTYX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 97,955 shares; 2024Q4: 124,530 shares; 2025Q1: 281,600 shares; 2025Q2: 168,600 shares; 2025Q3: 81,600 shares; 2025Q4: 81,600 shares 81,600$737K0.06%0Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 6,000 shares; 2025Q4: 7,000 shares 7,000$715K0.05%+1,000Timeline
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 200 shares; 2024Q4: 55,400 shares; 2025Q1: 42,800 shares; 2025Q2: 63,424 shares; 2025Q3: 42,900 shares; 2025Q4: 42,900 shares 42,900$712K0.05%0Timeline
LRMRLARIMAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 237,605 shares; 2025Q3: 235,689 shares; 2025Q4: 185,689 shares 185,689$707K0.05%-50,000Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 20,000 shares; 2025Q4: 20,000 shares 20,000$691K0.05%0Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 20,400 shares; 2024Q4: not reported; 2025Q1: 313,354 shares; 2025Q2: 128,767 shares; 2025Q3: 82,591 shares; 2025Q4: 58,091 shares 58,091$689K0.05%-24,500Timeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,442 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 11,842 shares; 2025Q3: 11,842 shares; 2025Q4: 6,842 shares 6,842$688K0.05%-5,000Timeline
ASMBASSEMBLY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 18,947 shares; 2025Q4: 19,747 shares 19,747$672K0.05%+800Timeline
FWRDFORWARD AIR CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 26,635 shares 26,635$666K0.05%newTimeline
GOSSGOSSAMER BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 416,958 shares; 2024Q4: 295,613 shares; 2025Q1: 227,228 shares; 2025Q2: 227,228 shares; 2025Q3: 212,531 shares; 2025Q4: 212,531 shares 212,531$659K0.05%0Timeline
ENTAENANTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 41,357 shares 41,357$652K0.05%newTimeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 11,187 shares; 2024Q4: not reported; 2025Q1: 132,780 shares; 2025Q2: 142,780 shares; 2025Q3: 20,840 shares; 2025Q4: 20,840 shares 20,840$632K0.05%0Timeline
NGNENEUROGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 553 shares; 2024Q4: not reported; 2025Q1: 27,925 shares; 2025Q2: 29,625 shares; 2025Q3: 30,633 shares; 2025Q4: 30,633 shares 30,633$631K0.05%0Timeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 127,159 shares; 2024Q4: 58,708 shares; 2025Q1: 62,603 shares; 2025Q2: 73,505 shares; 2025Q3: 56,007 shares; 2025Q4: 30,007 shares 30,007$626K0.05%-26,000Timeline
SRPTSAREPTA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,100 shares; 2024Q4: 40,002 shares; 2025Q1: 122,921 shares; 2025Q2: 210,313 shares; 2025Q3: 349,807 shares; 2025Q4: 28,866 shares 28,866$621K0.05%-320,941Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 700 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,020 shares 1,020$578K0.04%newTimeline
KYTXKYVERNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 57,428 shares 57,428$540K0.04%newTimeline
BABAALIBABA GROUP HLDG LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,578 shares; 2025Q4: 3,578 shares 3,578$524K0.04%0Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 50 shares; 2024Q4: not reported; 2025Q1: 1,490 shares; 2025Q2: 1,054 shares; 2025Q3: 4,895 shares; 2025Q4: 895 shares 895$521K0.04%-4,000Timeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 54,358 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 50,000 shares 50,000$518K0.04%newTimeline
CNTXCONTEXT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 373,835 shares; 2024Q4: 351,094 shares; 2025Q1: 351,094 shares; 2025Q2: 351,094 shares; 2025Q3: 351,094 shares; 2025Q4: 351,094 shares 351,094$516K0.04%0Timeline
GTERUGLOBA TERRA ACQUISITION CORQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares; 2025Q4: 50,000 shares 50,000$514K0.04%0Timeline
USFRWISDOMTREE TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,000 shares; 2024Q4: 10,000 shares; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares 10,000$503K0.04%0Timeline
APLSAPELLIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 17,252 shares; 2024Q4: 15,000 shares; 2025Q1: 17,000 shares; 2025Q2: 17,000 shares; 2025Q3: 20,000 shares; 2025Q4: 20,000 shares 20,000$502K0.04%0Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 4,250 shares; 2025Q2: 2,500 shares; 2025Q3: not reported; 2025Q4: 2,147 shares 2,147$492K0.04%newTimeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,500 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,000 shares 5,000$477K0.04%newTimeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares 30,000$462K0.03%newTimeline
ELANELANCO ANIMAL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,000 shares 20,000$453K0.03%newTimeline
PYPDPOLYPID LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 93,902 shares; 2024Q4: 80,080 shares; 2025Q1: 80,080 shares; 2025Q2: 103,950 shares; 2025Q3: not reported; 2025Q4: 103,950 shares 103,950$451K0.03%newTimeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 557,159 shares; 2024Q4: 337,676 shares; 2025Q1: 266,176 shares; 2025Q2: 441,176 shares; 2025Q3: 456,176 shares; 2025Q4: 336,176 shares 336,176$444K0.03%-120,000Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,500 shares 1,500$442K0.03%newTimeline
NVCRNOVOCURE LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 34,000 shares; 2025Q4: 34,000 shares 34,000$440K0.03%0Timeline
CORZCORE SCIENTIFIC INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares 30,000$437K0.03%newTimeline
OMEROMEROS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 25,000 shares 25,000$429K0.03%newTimeline
KURAKURA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 30,000 shares; 2024Q4: not reported; 2025Q1: 25,000 shares; 2025Q2: 34,300 shares; 2025Q3: 55,000 shares; 2025Q4: 40,000 shares 40,000$416K0.03%-15,000Timeline
VTGNVISTAGEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 163,078 shares; 2024Q4: 121,461 shares; 2025Q1: 420,765 shares; 2025Q2: 420,765 shares; 2025Q3: 113,062 shares; 2025Q4: 623,575 shares 623,575$413K0.03%+510,513Timeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,637 shares; 2024Q4: not reported; 2025Q1: 22,641 shares; 2025Q2: 32,341 shares; 2025Q3: 24,341 shares; 2025Q4: 34,277 shares 34,277$387K0.03%+9,936Timeline
KROSKEROS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 445,068 shares; 2024Q4: 23,246 shares; 2025Q1: 1,486,461 shares; 2025Q2: 5,389,264 shares; 2025Q3: 5,389,264 shares; 2025Q4: 18,851 shares 18,851$384K0.03%-5,370,413Timeline
KPTIKARYOPHARM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 25,000 shares; 2025Q4: 50,000 shares 50,000$368K0.03%+25,000Timeline
KIDSORTHOPEDIATRICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 19,845 shares 19,845$352K0.03%newTimeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 35,000 shares; 2024Q4: 35,000 shares; 2025Q1: 10,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 45,000 shares 45,000$351K0.03%newTimeline
AUPHAURINIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares; 2025Q3: not reported; 2025Q4: 22,000 shares 22,000$351K0.03%newTimeline
DAYDAYFORCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 10,000 shares; 2025Q4: 5,000 shares 5,000$346K0.03%-5,000Timeline
TXMDTHERAPEUTICSMD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 270,160 shares; 2024Q4: 270,160 shares; 2025Q1: 270,160 shares; 2025Q2: 209,210 shares; 2025Q3: 209,210 shares; 2025Q4: 209,210 shares 209,210$341K0.03%0Timeline
KPRXKIORA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 196,551 shares; 2024Q4: 200,221 shares; 2025Q1: 194,665 shares; 2025Q2: 167,111 shares; 2025Q3: 167,941 shares; 2025Q4: 167,941 shares 167,941$331K0.02%0Timeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 21,000 shares 21,000$324K0.02%newTimeline
SGRYSURGERY PARTNERS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 40,000 shares; 2025Q2: 40,000 shares; 2025Q3: 20,000 shares; 2025Q4: 20,000 shares 20,000$309K0.02%0Timeline
JDJD.COM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares 10,000$287K0.02%0Timeline
PROCAP ACQUISITION CORPPROCAP ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,680 shares; 2025Q3: 26,940 shares; 2025Q4: 26,940 shares 26,940$276K0.02%0
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,500 shares 3,500$273K0.02%newTimeline
IDXXIDEXX LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 400 shares 400$271K0.02%newTimeline
SPROSPERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 743,459 shares; 2024Q4: 801,277 shares; 2025Q1: 801,277 shares; 2025Q2: 143,917 shares; 2025Q3: 115,539 shares; 2025Q4: 113,839 shares 113,839$265K0.02%-1,700Timeline
CATXPERSPECTIVE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 95,193 shares 95,193$262K0.02%newTimeline
IMMXIMMIX BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 50,000 shares 50,000$262K0.02%newTimeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 15,816 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 140,000 shares 140,000$256K0.02%newTimeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 350,206 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares; 2025Q3: not reported; 2025Q4: 12,000 shares 12,000$252K0.02%newTimeline
OGNORGANON & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,100 shares; 2024Q4: 40,200 shares; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares; 2025Q3: 10,000 shares; 2025Q4: 35,000 shares 35,000$251K0.02%+25,000Timeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 48,000 shares 48,000$241K0.02%newTimeline
PEPGPEPGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 20,352 shares; 2025Q2: 20,352 shares; 2025Q3: 36,842 shares; 2025Q4: 36,842 shares 36,842$240K0.02%0Timeline
EOLSEVOLUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 35,859 shares 35,859$238K0.02%newTimeline
ACHVACHIEVE LIFE SCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 91 shares; 2024Q4: 13,173 shares; 2025Q1: 43,173 shares; 2025Q2: 43,173 shares; 2025Q3: 47,800 shares; 2025Q4: 47,800 shares 47,800$238K0.02%0Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 40,440 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 22,875 shares; 2025Q3: 13,705 shares; 2025Q4: 13,705 shares 13,705$231K0.02%0Timeline
RXSTRXSIGHT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 21,803 shares 21,803$227K0.02%newTimeline
MISTMILESTONE PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 27,931 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 100,100 shares 100,100$202K0.02%newTimeline
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 77,593 shares 77,593$188K0.01%newTimeline
TRAWTRAWS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 154,431 shares 154,431$175K0.01%newTimeline
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 14,143 shares; 2024Q4: 35,843 shares; 2025Q1: 35,743 shares; 2025Q2: 10,000 shares; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares 10,000$162K0.01%0Timeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 130,000 shares; 2025Q3: not reported; 2025Q4: 30,866 shares 30,866$149K0.01%newTimeline
VYNEVYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 152,865 shares; 2024Q4: not reported; 2025Q1: 70,419 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 253,791 shares 253,791$147K0.01%newTimeline
QNCXQUINCE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 142,958 shares; 2024Q4: 142,958 shares; 2025Q1: 142,958 shares; 2025Q2: 142,958 shares; 2025Q3: 775,034 shares; 2025Q4: 42,912 shares 42,912$144K0.01%-732,122Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 40,290 shares; 2024Q4: 18,000 shares; 2025Q1: 18,643 shares; 2025Q2: 18,643 shares; 2025Q3: 18,643 shares; 2025Q4: 23,643 shares 23,643$144K0.01%+5,000Timeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 15,000 shares; 2024Q4: 15,000 shares; 2025Q1: 15,000 shares; 2025Q2: 35,000 shares; 2025Q3: 35,000 shares; 2025Q4: 35,000 shares 35,000$143K0.01%0Timeline
VYGRVOYAGER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 40,634 shares; 2024Q4: 126,792 shares; 2025Q1: 75,545 shares; 2025Q2: 79,945 shares; 2025Q3: 35,000 shares; 2025Q4: 35,000 shares 35,000$138K0.01%0Timeline
ZONEZONE FRONTIER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 521,980 shares 521,980$136K0.01%newTimeline
CMMBCHEMOMAB THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 80,000 shares 80,000$132K0.01%newTimeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 101,008 shares; 2024Q4: 101,008 shares; 2025Q1: 101,008 shares; 2025Q2: 101,008 shares; 2025Q3: 101,008 shares; 2025Q4: 101,008 shares 101,008$126K0.01%0Timeline
GENERATION BIO COGENERATION BIO COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 22,144 shares; 2025Q4: 22,144 shares 22,144$126K0.01%0
NEUPNEUPHORIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares 30,000$116K0.01%newTimeline
CLOVCLOVER HEALTH INVESTMENTS COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 23,300 shares; 2025Q1: 28,300 shares; 2025Q2: 48,300 shares; 2025Q3: 48,300 shares; 2025Q4: 48,300 shares 48,300$114K0.01%0Timeline
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 50,000 shares; 2025Q3: 50,000 shares; 2025Q4: 80,000 shares 80,000$108K0.01%+30,000Timeline
BCABBIOATLA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 170,506 shares; 2025Q3: not reported; 2025Q4: 183,107 shares 183,107$104K0.01%newTimeline
SABSSAB BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 15,000 shares; 2025Q4: 26,344 shares 26,344$98.5K0.01%+11,344Timeline
KYNBKYNTRA BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 10,469 shares 10,469$91.9K0.01%newTimeline
RZLTREZOLUTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,571,705 shares; 2024Q4: 1,359,208 shares; 2025Q1: 1,116,047 shares; 2025Q2: 989,297 shares; 2025Q3: 815,975 shares; 2025Q4: 38,679 shares 38,679$91.3K0.01%-777,296Timeline
NMRANEUMORA THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 68,608 shares; 2025Q1: 26,108 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 50,600 shares 50,600$90.6K0.01%newTimeline
PLRXPLIANT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 246,128 shares; 2024Q4: 134,798 shares; 2025Q1: not reported; 2025Q2: 82,189 shares; 2025Q3: not reported; 2025Q4: 73,819 shares 73,819$90.1K0.01%newTimeline
LITSLITE STRATEGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 292,397 shares; 2025Q4: 67,292 shares 67,292$88.8K0.01%-225,105Timeline
IRDOPUS GENETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 40,000 shares 40,000$80.4K0.01%newTimeline
KALAKALA BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 306,067 shares; 2024Q4: 220,373 shares; 2025Q1: 298,955 shares; 2025Q2: 149,830 shares; 2025Q3: 141,995 shares; 2025Q4: 141,480 shares 141,480$78.6K0.01%-515Timeline
VERUVERU INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 35,000 shares 35,000$74.9K0.01%newTimeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 64,245 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,000 shares 20,000$66.4K<0.01%newTimeline
MREOMEREO BIOPHARMA GROUP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,000 shares; 2024Q4: 10,000 shares; 2025Q1: 10,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 150,000 shares 150,000$62.5K<0.01%newTimeline
BMEABIOMEA FUSION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 43,420 shares 43,420$53.8K<0.01%newTimeline
ASPCRA SPAC III ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 215,000 shares; 2025Q2: 215,000 shares; 2025Q3: 215,000 shares; 2025Q4: 215,000 shares 215,000$40.9K<0.01%0Timeline
ATYRATYR PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 175,000 shares; 2025Q4: 50,685 shares 50,685$39.7K<0.01%-124,315Timeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 20,394 shares; 2025Q1: 20,394 shares; 2025Q2: 10,000 shares; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares 10,000$20.2K<0.01%0Timeline
IVFINVO FERTILITY INC COM PAR $0.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 26,722 shares 26,722$20.1K<0.01%newTimeline
IOBTQIO BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 24,964 shares 24,964$15.2K<0.01%newTimeline
CHRSCOHERUS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,366 shares; 2025Q3: 10,366 shares; 2025Q4: 10,366 shares 10,366$14.7K<0.01%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
IWMISHARES TR SHSput27,500$6.77Mnew
AAMAA MISSION ACQUISITION COR-A ORD SHS CL Acall405,089$4.32M0
GUTSFRACTYL HEALTH INC COMcall1,428,571$3.14Mnew
AQSTAQUESTIVE THERAPEUTICS INC Stockput254,000$1.64Mnew
GOSSGOSSAMER BIO INC Stockput463,200$1.44Mnew
OMEROMEROS CORP COMput75,000$1.29Mnew
URGNUROGEN PHARMA LTD COMMON STOCKcall40,000$937K0
KVACFKEEN VISION ACQUISITION CORP SHScall75,000$881K0
LQDALIQUIDIA CORPORATION Stockput24,500$845Knew
FULCFULCRUM THERAPEUTICS INC COMMON STOCKcall65,000$735K-10,000
QUREUNIQURE NV SHScall30,000$718K-170,000
CTMXCYTOMX THERAPEUTICS INC. COMMON STOCKcall100,000$426Knew
QNCXQUINCE THERAPEUTICS INC COMput80,000$268Knew
REPLREPLIMUNE GROUP INC COMMON STOCKcall25,000$243K-25,000
RAREULTRAGENYX PHARMACEUTICAL IN COMcall10,000$230Knew
DYNDYNE THERAPEUTICS INC Stockcall10,000$196K-10,000
OTLKOUTLOOK THERAPEUTICS INC COMput100,000$158Knew
INOINOVIO PHARMACEUTICALS INC COMMON STOCKcall75,500$131Knew
GOSSGOSSAMER BIO INC Stockcall35,100$109K-20,000
STISOLIDION TECHNOLOGY INC COM NEWcall13,500$95.7K0
VTGNVISTAGEN THERAPEUTICS INC COMput120,000$79.4Knew

Sold out in Q4 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
89BIO INC89BIO INC2,113,153$31.1Mshares
SPYSTATE STR SPDR S&P 500 ETF T45,500$30.3Mput
MTSRMETSERA INC152,521$7.98Mshares
VERONA PHARMA PLCVERONA PHARMA PLC51,450$5.49Mshares
BRIDGEBIO PHARMA INCBRIDGEBIO PHARMA INC45,000$4.45Mprincipal
XBISPDR SERIES TRUST40,000$4.01Mput
MERUS N VMERUS N V33,313$3.14Mshares
BRIDGEBIO PHARMA INCBRIDGEBIO PHARMA INC20,000$2.81Mprincipal
ASPCA SPAC III ACQUISITION CORP215,000$2.22Mshares
KRROKORRO BIO INC40,235$1.93Mshares
MLTXMOONLAKE IMMUNOTHERAPEUTICS151,495$1.09Mshares
WVEWAVE LIFE SCIENCES LTD119,067$872Kshares
LLYELI LILLY & CO1,000$763Kshares
LENZLENZ THERAPEUTICS INC11,619$541Kshares
INTELLIGENT BIO SOLUTIONS ININTELLIGENT BIO SOLUTIONS IN426,433$435Kshares
GPCRSTRUCTURE THERAPEUTICS INC15,200$426Kshares
AVTXAVALO THERAPEUTICS INC32,393$412Kshares
NVCRNOVOCURE LTD30,000$388Kcall
BHVNBIOHAVEN LTD25,000$375Kcall
ANSCAGRICULTURE & NAT SOL ACQ CO27,062$296Kshares
AKROAKERO THERAPEUTICS INC6,143$292Kshares
HRMYHARMONY BIOSCIENCES HLDGS IN10,245$282Kshares
RAREULTRAGENYX PHARMACEUTICAL IN9,000$271Kshares
OLMAOLEMA PHARMACEUTICALS INC25,000$245Kcall
ALMSALUMIS INC61,291$245Kshares
FLNAFILANA THERAPEUTICS INC81,000$236Kshares
IFRXINFLARX NV159,479$214Kshares
DAWNDAY ONE BIOPHARMACEUTICALS I28,023$198Kshares
ATYRATYR PHARMA INC222,500$161Kput
MLTXMOONLAKE IMMUNOTHERAPEUTICS17,000$122Kcall
IOVAIOVANCE BIOTHERAPEUTICS INC50,000$108Kcall
ATYRATYR PHARMA INC84,800$61.2Kcall
BIOMX INCBIOMX INC77,656$40.8Kshares
NERVMINERVA NEUROSCIENCES INC12,406$26.1Kshares
MURAL ONCOLOGY PUB LTD COMURAL ONCOLOGY PUB LTD CO11,855$24.5Kshares
GUTSFRACTYL HEALTH INC13,097$20.8Kshares
CYPHCYPHERPUNK TECHNOLOGIES INC25,830$11.7Kshares

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001940272-26-000002 superseded2026-02-17acceptance time not in the bulk data set
13F-HR/A 0001940272-26-000003 baserestatement2026-02-18acceptance time not in the bulk data set